TL;DR
This study engineers Mycolicibacterium to improve the production of androstenedione (AD), a key intermediate for steroid drugs. By modifying a redox-sensitive enzyme (FadA5) and enhancing cellular respiration and metabolism, they achieved a significant increase in AD yield and production efficiency, paving the way for more robust industrial bioproduction.
What Problem Does This Paper Address?
Steroid drugs are a crucial class of pharmaceuticals, and their production often relies on intermediates like androstenedione (AD). While microbial transformation of phytosterols into AD offers an alternative to chemical synthesis, optimizing this process remains a challenge. A key enzyme in this pathway is Acetyl-CoA acetyltransferase (FadA5), a thiolase. However, FadA5's activity is known to be sensitive to the cellular redox environment, limiting its efficiency. Furthermore, the metabolic byproducts of phytosterol degradation, such as reactive oxygen species (ROS) and propionyl-CoA, can negatively impact cell viability and overall production. This paper aims to address these limitations by systematically investigating FadA5's role, mitigating its redox sensitivity, and improving the cellular environment for enhanced AD production.
Methods
The researchers employed a multi-pronged genetic engineering approach:
- Enzyme Modification: They identified a critical cysteine residue (C87) in FadA5 that contributes to its redox sensitivity. By mutating this cysteine to alanine (FadA5C87A), they aimed to reduce the enzyme's susceptibility to redox fluctuations.
- Gene Knockout and Complementation: They created a fadA5 knockout strain (MSPAfA5) to confirm FadA5's essential role in AD production and then complemented it with either the wild-type or mutated FadA5 gene.
- Co-expression of Enhancing Factors: To improve the cellular environment, they co-expressed Vitreoscilla hemoglobin (VHb) and the propionyl-CoA metabolism regulator PrpR. VHb is known to enhance oxygen supply and reduce ROS, while PrpR aids in the efficient metabolism of propionyl-CoA.
- Fermentation Optimization: They utilized both resting cell experiments to study the effect of redox potential and repeated batch fermentation to assess the engineered strains' production performance under industrially relevant conditions.
- Analytical Techniques: Standard methods like cell dry weight (DCW) determination, HPLC for AD yield measurement, and fluorescent probes (DCFH-DA) for ROS detection were employed. Cell viability was assessed using a modified CCK-8 assay.
Datasets
Not discussed in the paper. The study focuses on experimental data generated from engineered microbial strains.
Key Insights and Ideas
- FadA5 is a critical bottleneck: Deleting the fadA5 gene significantly impaired AD production, confirming its central role in the phytosterol degradation pathway.
- Redox sensitivity is a major limitation: FadA5's activity is strongly influenced by the cellular redox potential, with reduced activity in oxidizing environments. This sensitivity directly impacts AD production.
- Targeted mutation can overcome redox sensitivity: Mutating the C87 cysteine in FadA5 to alanine significantly improved its performance in oxidizing conditions, enhancing substrate tolerance and biotransformation capacity.
- Improving cellular respiration and metabolism is key: Co-expressing VHb and PrpR effectively reduced intracellular ROS levels and improved cell viability, creating a more favorable environment for AD production.
- Synergistic engineering yields superior results: Combining the FadA5 mutation with VHb and PrpR co-expression led to the highest AD yields and production efficiencies.
Key Results
- The engineered strain MSP-fA5C87A-VP/ΔfA5 achieved an AD yield of 2.541 g/L, representing a 16.83% increase compared to the control strain.
- In repeated batch fermentation, the production efficiency of MSP-fA5C87A-VP/ΔfA5 reached 0.658 g/L/d, which is 1.82 times higher than the control strain.
- Resting cell experiments showed that the mutated FadA5 (C87A) exhibited better AD production at higher redox potentials (more oxidizing conditions).
- The engineered strain MSP-fA5C87A-VP/ΔfA5 demonstrated improved cell viability and reduced ROS levels compared to the control and the single-mutant strains.
Limitations and Future Work
- Substrate Concentration Impact: While the engineered strain showed improved substrate tolerance, cell viability still decreased with increasing phytosterol concentration, suggesting potential for further optimization in handling high substrate loads.
- Metabolic Byproduct Toxicity: The paper notes that excessive ROS and propionyl-CoA contribute to decreased cell viability. While VHb and PrpR helped, further investigation into managing these byproducts could lead to even greater improvements.
- Scale-up: The study demonstrates promising results in batch and repeated batch fermentation. Future work could focus on scaling up these processes to industrial levels and evaluating their economic feasibility.
- Broader Strain Engineering: The findings provide a theoretical basis for engineering other Mycolicibacterium strains or related microorganisms for steroid precursor production.
This research offers a significant step forward in optimizing the microbial production of AD, highlighting the power of targeted enzyme engineering and metabolic pathway optimization for industrial biotechnology.
Summary updated